Performance of the BioGaming Device (YuGo) in the Support of Physical

See also
Status	Clinical Trial	Phase
Completed	`NCT02764905` - Intensive Cognitive and Physical Rehabilitation Program
Completed	`NCT05274152` - Using Immersive Virtual Reality for Children's Lower Limb Rehabilitation	N/A
Completed	`NCT04538248` - Efficiency of Combined Rehabilitation Programs Including Resistance and Endurance Exercises on Functional Capacities, Quality of Life and Daily Level of Activities in Hemodialysis Patients

See also

Status

Clinical Trial

Phase

Completed

NCT02764905 - Intensive Cognitive and Physical Rehabilitation Program

Completed

NCT05274152 - Using Immersive Virtual Reality for Children's Lower Limb Rehabilitation

N/A

Completed

NCT04538248 - Efficiency of Combined Rehabilitation Programs Including Resistance and Endurance Exercises on Functional Capacities, Quality of Life and Daily Level of Activities in Hemodialysis Patients

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT02373748
Study type	Interventional
Source	BioGaming Ltd.
Contact
Status	Completed
Phase	N/A
Start date	March 2015
Completion date	June 2015

Performance of the BioGaming Device (YuGo) in the Support of Physical Rehabilitation

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms